CD4 and COVID-19: Based on the results of our meta-analysis, especially promising markers are NLR, IL-6, serum ferritin, lymphocyte and CD4 counts, D-dimer, and troponin I. The clinical value of these markers should be explored further to assess the risk of severe or critical disease and to monitor the clinical course of COVID-19 [42].